213 related articles for article (PubMed ID: 24069322)
1. Circulating CD36 is reduced in HNF1A-MODY carriers.
Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
[TBL] [Abstract][Full Text] [Related]
2. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
McDonald TJ; McEneny J; Pearson ER; Thanabalasingham G; Szopa M; Shields BM; Ellard S; Owen KR; Malecki MT; Hattersley AT; Young IS
Clin Chim Acta; 2012 May; 413(9-10):927-32. PubMed ID: 22360925
[TBL] [Abstract][Full Text] [Related]
4. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
[TBL] [Abstract][Full Text] [Related]
5. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
[TBL] [Abstract][Full Text] [Related]
6. Maturity onset diabetes of the young due to
Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
[TBL] [Abstract][Full Text] [Related]
7. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
8. Mutations in HNF1A result in marked alterations of plasma glycan profile.
Thanabalasingham G; Huffman JE; Kattla JJ; Novokmet M; Rudan I; Gloyn AL; Hayward C; Adamczyk B; Reynolds RM; Muzinic A; Hassanali N; Pucic M; Bennett AJ; Essafi A; Polasek O; Mughal SA; Redzic I; Primorac D; Zgaga L; Kolcic I; Hansen T; Gasperikova D; Tjora E; Strachan MW; Nielsen T; Stanik J; Klimes I; Pedersen OB; Njølstad PR; Wild SH; Gyllensten U; Gornik O; Wilson JF; Hastie ND; Campbell H; McCarthy MI; Rudd PM; Owen KR; Lauc G; Wright AF
Diabetes; 2013 Apr; 62(4):1329-37. PubMed ID: 23274891
[TBL] [Abstract][Full Text] [Related]
9. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
Thanabalasingham G; Shah N; Vaxillaire M; Hansen T; Tuomi T; Gašperíková D; Szopa M; Tjora E; James TJ; Kokko P; Loiseleur F; Andersson E; Gaget S; Isomaa B; Nowak N; Raeder H; Stanik J; Njolstad PR; Malecki MT; Klimes I; Groop L; Pedersen O; Froguel P; McCarthy MI; Gloyn AL; Owen KR
Diabetologia; 2011 Nov; 54(11):2801-10. PubMed ID: 21814873
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
[TBL] [Abstract][Full Text] [Related]
11. Identification of circulating microRNAs in HNF1A-MODY carriers.
Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
[TBL] [Abstract][Full Text] [Related]
12. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
13. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
[TBL] [Abstract][Full Text] [Related]
14. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
[TBL] [Abstract][Full Text] [Related]
15. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
16. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.
Szopa M; Matejko B; Ucieklak D; Uchman A; Hohendorff J; Mrozińska S; Głodzik W; Zapała B; Płatek T; Solecka I; Sani CM; Małecki MT
Endocrine; 2019 May; 64(2):246-253. PubMed ID: 30421137
[TBL] [Abstract][Full Text] [Related]
17. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
[TBL] [Abstract][Full Text] [Related]
18. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
[TBL] [Abstract][Full Text] [Related]
19. New clinical screening strategy to distinguish
Ma Y; Gong S; Wang X; Cai X; Xiao X; Gu W; Yang J; Zhong L; Xiao J; Li M; Liu W; Zhang S; Zhou X; Li Y; Zhou L; Zhu Y; Luo Y; Ren Q; Huang X; Gao X; Zhang X; Zhang R; Chen L; Wang F; Wang Q; Hu M; Han X; Ji L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32238361
[TBL] [Abstract][Full Text] [Related]
20. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
